Burlingame, CA, United States of America

Robert Kotmel

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 2,088(Granted Patents)


Company Filing History:


Years Active: 2001-2019

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations of Robert Kotmel in Pulmonary Medicine

Introduction

Robert Kotmel is a notable inventor based in Burlingame, California, recognized for his significant contributions to pulmonary medicine. With a total of 18 patents to his name, he has developed innovative solutions aimed at improving the diagnosis and treatment of lung diseases. His work has had a profound impact on the field, particularly in the area of minimally invasive procedures.

Latest Patents

Among his latest patents is a method and apparatus for endobronchial diagnosis. This invention provides systems, methods, devices, and kits for assessing the level of pulmonary disease in individual lung compartments. By measuring these compartments, the level of disease can be more precisely defined, allowing for better treatment options. Another significant patent is for a pulmonary occlusal stent delivery catheter, which offers methods and systems for performing lung volume reduction in patients with chronic obstructive pulmonary disease. This minimally invasive approach isolates target lung tissue segments and occludes lung passageways, enhancing patient outcomes.

Career Highlights

Throughout his career, Robert Kotmel has worked with prominent companies in the medical field, including Pulmonx Corporation and Cytyc Corporation. His experience in these organizations has allowed him to refine his inventions and contribute to advancements in pulmonary health.

Collaborations

Robert has collaborated with esteemed colleagues such as Peter P. Soltesz and Rodney A. Perkins, further enriching his work and expanding the impact of his innovations.

Conclusion

Robert Kotmel's contributions to pulmonary medicine through his patents and collaborations highlight his dedication to improving patient care. His innovative approaches continue to shape the future of lung disease treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…